“…Therefore, they present an inherent thrombotic propensity, which encompasses all elements of Virchow’s triad and thus, they often receive anticoagulation therapy, which further increases the risk of bleeding. 5 , 12 , 13 , 14 Therefore, it could be speculated that an additional coagulopathy burden due to COVID-19 would be devastating for these high-risk patients ( Figure 1 ).…”